Stryker Corporation
SYK
#107
Rank
โ‚น12.039 T
Marketcap
โ‚น31,582
Share price
1.17%
Change (1 day)
26.97%
Change (1 year)
Categories
Stryker Corporation is an American company that manufactures orthopedic and surgical implants and instruments as well as products for patient transportation.

P/E ratio for Stryker Corporation (SYK)

P/E ratio as of December 2024 (TTM): 54.4

According to Stryker Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 54.4464. At the end of 2022 the company had a P/E ratio of 39.2.

P/E ratio history for Stryker Corporation from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202239.2-22.37%
202150.6-11.91%
202057.452.25%
201937.7128.19%
201816.5-70.88%
201756.7108.77%
201627.211.66%
201524.3-58.99%
201459.3109.23%
201328.476.38%
201216.112.87%
201114.2-14.86%
201016.7-7.34%
200918.126.99%
200814.2-52.62%
200730.04%
200628.93.91%
200527.8-36.69%
200443.911.97%
200339.2-2.53%
200240.2-4.98%
200142.3

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
21.8-59.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
30.0-44.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
111 103.98%๐Ÿ‡บ๐Ÿ‡ธ USA
32.1-41.09%๐Ÿ‡บ๐Ÿ‡ธ USA
5.68-89.57%๐Ÿ‡บ๐Ÿ‡ธ USA
18.1-66.68%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
-9.86-118.11%๐Ÿ‡บ๐Ÿ‡ธ USA
32.8-39.83%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.